7月 2026
- 首頁
- Vernal Biosciences, Inc.
7月 2026Vernal Biosciences, Inc.的市場佔有率分析
Vernal Biosciences is an mRNA CDMO delivering high-purity mRNA manufacturing, LNP formulation, and GMP support for vaccines, gene therapies, and mRNA therapeutics.
Vernal Biosciences, Inc.(包含公司地區)
查看更多網站流量與參與度資訊- vernal.bio
Vernal Biosciences, Inc.截至 7月 2026 的總收入為 2M - 5M
Vernal Biosciences, Inc. 熱門網域產生的總收入
Vernal Biosciences, Inc. 熱門網域 3 年內的總收入
Vernal Biosciences, Inc. 熱門網域的總收入
Vernal Biosciences, Inc.的熱門網域總造訪量
了解Vernal Biosciences, Inc.市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Vernal Biosciences, Inc.的熱門網域平均造訪時長
分析Vernal Biosciences, Inc.參與度指標。
過去 3 個月平均造訪時長
子公司細目
Vernal Biosciences, Inc.的熱門網域平均頁面瀏覽量
了解Vernal Biosciences, Inc.如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Vernal Biosciences, Inc.
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Repair Biotechnologies, Inc. partners with Vernal Biosciences.By partnering with Vernal, Repair reduced the friction around on-time supply of mRNA for critical preclinical studies.
11月 13, 2024閱讀更多
新聞Vernal Biosciences hired Jim Petrilla as Chief Executive Officer (CEO) and Board Director on Oct 31st '24.Vernal Biosciences Inc., a leader in mRNA and lipid nanoparticle (LNP) development, manufacturing, and analytics, today announces the appointment of Jim Petrilla as Chief Executive Officer (CEO) and Board Director.
10月 31, 2024閱讀更多
新聞Vernal Biosciences hires Sven Lee as Chief Commercial Officer.COLCHESTER, Vt.-(BUSINESS WIRE)-Vernal Biosciences, a leading manufacturing and services company specializing in mRNA and lipid nanoparticle (LNP) formulation, proudly announces the additions of Sven Lee, Chief Commercial Officer, and Richard P. Hamel, Chief Financial Officer to its leadership team.
1月 8, 2024閱讀更多
查看所有Vernal Biosciences, Inc.信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
